Even though 64Cu-complexed Plerixafor AMD3465 showed high tumor and liver uptake in vivo, the additional positive charge from radiometal might prevent it from crossing BBB and target CXCR4-positive gliomas. This evidence concerns the gene CXCR4 and glioma.